Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

PREMOD2 With Near Infrared Spectroscopy Sub-study
PREMOD2 NIRS Substudy - A Randomized Trial of Cerebral Oxygen Saturation in Infants Randomized to Umbilical Cord Milking or Delayed Cord Clamping
Status: Enrolling
Updated:  12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
PREMOD2 With Near Infrared Spectroscopy Sub-study
PREMOD2 NIRS Substudy - A Randomized Trial of Cerebral Oxygen Saturation in Infants Randomized to Umbilical Cord Milking or Delayed Cord Clamping
Status: Enrolling
Updated: 12/31/1969
Sharp Mary Birch Hospital for Women and Newborns
mi
from
San Diego, CA
Click here to add this to my saved trials
PREMOD2 With Near Infrared Spectroscopy Sub-study
PREMOD2 NIRS Substudy - A Randomized Trial of Cerebral Oxygen Saturation in Infants Randomized to Umbilical Cord Milking or Delayed Cord Clamping
Status: Enrolling
Updated:  12/31/1969
Governors of University of Alberta
mi
from
Edmonton,
PREMOD2 With Near Infrared Spectroscopy Sub-study
PREMOD2 NIRS Substudy - A Randomized Trial of Cerebral Oxygen Saturation in Infants Randomized to Umbilical Cord Milking or Delayed Cord Clamping
Status: Enrolling
Updated: 12/31/1969
Governors of University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Duarte, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Miami, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Maywood, IL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Indianapolis, IN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Scarborough, ME
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Baltimore, MD
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Omaha, NE
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Las Vegas, NV
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Brooklyn, NY
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kettering, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kettering, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Dallas, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Phoenix, AZ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Orange, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Orange, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
San Francisco, CA
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Tallahassee, FL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Park Ridge, IL
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Hackensack, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Cincinnati, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Hilliard, OH
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Hilliard, OH
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Galveston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Galveston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
Newark, NJ
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated:  12/31/1969
Site
mi
from
La Rioja,
Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Status: Enrolling
Updated: 12/31/1969
Site
mi
from
La Rioja,
Click here to add this to my saved trials
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated:  12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Cervix Image Sharing Protocol (CISP)
Cervix Image Sharing Protocol (CISP)
Status: Enrolling
Updated: 12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Inovium Ovarian Rejuvenation Trials
Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation
Status: Enrolling
Updated:  12/31/1969
Center for Advanced Genetics
mi
from
Carlsbad, CA
Inovium Ovarian Rejuvenation Trials
Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation
Status: Enrolling
Updated: 12/31/1969
Center for Advanced Genetics
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Early DHA Supplementation in Very Low Birth Weight Infants
Early DHA Supplementation in Very Low Birth Weight Infants
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Early DHA Supplementation in Very Low Birth Weight Infants
Early DHA Supplementation in Very Low Birth Weight Infants
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Early DHA Supplementation in Very Low Birth Weight Infants
Early DHA Supplementation in Very Low Birth Weight Infants
Status: Enrolling
Updated:  12/31/1969
North Shore University Health System
mi
from
Evanston, IL
Early DHA Supplementation in Very Low Birth Weight Infants
Early DHA Supplementation in Very Low Birth Weight Infants
Status: Enrolling
Updated: 12/31/1969
North Shore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Vaginal Tactile Imaging for Pelvic Floor Prolapse
Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
Status: Enrolling
Updated:  12/31/1969
The Pelvic Floor Institute
mi
from
Tampa, FL
Vaginal Tactile Imaging for Pelvic Floor Prolapse
Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
Status: Enrolling
Updated: 12/31/1969
The Pelvic Floor Institute
mi
from
Tampa, FL
Click here to add this to my saved trials